Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pseudomonas aeruginosa outer membrane and surface components comprise a heterogeneous group of molecules including outer membrane proteins (Omps), lipopolysaccharides, and exopolysaccharides like Psl and Pel. These structures are essential for the bacterium's environmental adaptation, mediating adhesion to host cells and the formation of highly resistant biofilms (Moradali et al., 2017, Science Signaling). In the context of human disease, these components act as potent virulence factors that facilitate colonization of the respiratory tract, particularly in patients with cystic fibrosis or those requiring mechanical ventilation (Guvener & Harwood, 2007, Molecular Microbiology). Because these molecules are surface-exposed, they are primary targets for the host immune system and for the development of novel therapeutics such as monoclonal antibodies and vaccines. For instance, the bispecific antibody MEDI3902 targets both the Psl exopolysaccharide and the PcrV protein to inhibit attachment and neutralize the Type III secretion system (DiGiandomenico et al., 2014, Science Translational Medicine). Despite their promise, the significant phenotypic diversity and ability of P. aeruginosa to modulate surface expression present substantial challenges for achieving broad-spectrum efficacy across different clinical isolates.
Opsonophagocytic killing, inhibition of bacterial adhesion, neutralization of virulence factors, and disruption of biofilm formation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas aeruginosa outer membrane and surface components (PA surface components).